» Articles » PMID: 18825621

Prevalence of Symptomatic Urinary Calculi in Kerman, Iran

Overview
Journal Urol J
Specialty Urology
Date 2008 Oct 1
PMID 18825621
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In a cross-sectional study, we evaluated the prevalence of symptomatic urinary calculi in Kerman, Iran.

Materials And Methods: A total of 2431 citizens of Kerman were surveyed from September of 2005 to April 2006. The study population was selected by cluster method from 5 different areas, and 100 houses in each area were randomly approached. Questions on the urinary symptoms consisted of flank pain, urogenital pain, dysuria or any difficulty in urination, and alterations in urine color. Individuals with a suspicion of urinary calculi based on their symptoms were evaluated by physical examination, laboratory investigations, and plain abdominal radiography. Ultrasonography and intravenous urography were done if required to confirm the diagnoses.

Results: Of 2431 individuals, 196 (8.1%) had symptoms in favor of urinary calculus diagnosis, of whom 47 (24.0%) had urinary calculi (prevalence of symptomatic urolithiasis was 1.9%). Of the patients, 35 (74.5%) were underweight. Compared to the other participants, the patients with urinary calculus were younger (P = .001) and a larger proportion of them had a positive family history of urinary calculi (14.9% versus 6.5%; P = .02) and were rug weavers and office employees. Dependency on opium and its derivative was significantly more frequent in patients with urinary calculi (25.5% versus 0.2%; P = .001).

Conclusion: This study showed that the prevalence of symptomatic urinary calculi in this hot and dry area is relatively high. According to our findings, the other factors including specific occupations, malnutrition, and substance use may also have influence on the rate of urinary calculus formation. Therefore, to prevention and early treatment of urinary calculi, evaluation of potential predisposing conditions should be considered with special attention to regional factors.

Citing Articles

Global Trends in Kidney Stone Awareness: A Time Series Analysis from 2004-2023.

Aiumtrakul N, Thongprayoon C, Suppadungsuk S, Krisanapan P, Pinthusopon P, Mao M Clin Pract. 2024; 14(3):915-927.

PMID: 38804404 PMC: 11130814. DOI: 10.3390/clinpract14030072.


Significance of TRPV5 and OPN biomarker levels in clinical diagnosis of patients with early urinary calculi.

Wu J, Zhao J, Zhao Z, Jin S, Yu Q Am J Transl Res. 2021; 13(6):6778-6783.

PMID: 34306426 PMC: 8290816.


Mirabegron in medical expulsive therapy for distal ureteral stones: a prospective, randomized, controlled study.

Tang Q, Wang D, Zhou S, Tao R World J Urol. 2021; 39(12):4465-4470.

PMID: 34241685 DOI: 10.1007/s00345-021-03772-9.


Pooled analysis of the efficacy and safety of adjunctive alpha-blocker therapy before ureteroscopy in the management of ureteral stones.

Tan H, Li Y, Zhang X, Mao X J Int Med Res. 2020; 48(6):300060520923878.

PMID: 32529861 PMC: 7294376. DOI: 10.1177/0300060520923878.


Efficacy of silodosin on the outcome of semi-rigid ureteroscopy for the management of large distal ureteric stones: blinded randomised trial.

Mohey A, Gharib T, Alazaby H, Khalil M, Abou-Taleb A, Noureldin Y Arab J Urol. 2018; 16(4):422-428.

PMID: 30534442 PMC: 6277265. DOI: 10.1016/j.aju.2018.07.002.